Ambrisentan Tablets Shortage

• • Ambrisentan oral tablet, Cipla USA, 10 mg, bottle, 30 count, NDC 69097-0387-02
  • Ambrisentan oral tablet, Teva, 10 mg, bottle, 30 count, NDC 00591-2406-30
  • Ambrisentan oral tablet, Zydus, 10 mg, bottle, 30 count, NDC 70710-1180-03
  • Ambrisentan oral tablet, Zydus, 5 mg, bottle, 30 count, NDC 70710-1179-03

• • Apotex has ambrisentan tablets available.
  • Cipla did not provide a reason for the shortage.
  • Mylan has ambrisentan tablets available.
  • Sun Pharma has ambrisentan tablets available.
  • Teva did not provide a reason for the shortage.
  • Zydus did not provide a reason for the shortage.
  • Gilead has Letairis tablets available.

• • Letairis oral tablet, Gilead, 10 mg, bottle, 10 count, NDC 61958-0802-05
  • Letairis oral tablet, Gilead, 10 mg, bottle, 30 count, NDC 61958-0802-01
  • Letairis oral tablet, Gilead, 5 mg, bottle, 10 count, NDC 61958-0801-05
  • Letairis oral tablet, Gilead, 5 mg, bottle, 30 count, NDC 61958-0801-01
  • Ambrisentan oral tablet, Apotex, 10 mg, bottle, 30 count, NDC 60505-4553-03
  • Ambrisentan oral tablet, Apotex, 5 mg, bottle, 30 count, NDC 60505-4552-03
  • Ambrisentan oral tablet, Cipla USA, 5 mg, bottle, 30 count, NDC 69097-0386-02
  • Ambrisentan oral tablet, Mylan (Viatris), 10 mg, bottle, 30 count, NDC 00378-4271-93
  • Ambrisentan oral tablet, Mylan (Viatris), 5 mg, bottle, 30 count, NDC 00378-4270-93
  • Ambrisentan oral tablet, Sun Pharma, 10 mg, bottle, 30 count, NDC 47335-0237-83
  • Ambrisentan oral tablet, Sun Pharma, 5 mg, bottle, 30 count, NDC 47335-0236-83
  • Ambrisentan oral tablet, Teva, 5 mg, bottle, 30 count, NDC 00591-2405-30

Estimated Resupply Dates

• • Cipla has ambrisentan 10 mg tablets on back order and the company cannot estimate a release date.
  • Teva has ambrisentan 10 mg tablets on back order and the company estimates a release date in late-May 2024.
  • Zydus has ambrisentan 5 mg and 10 mg tablets on allocation.